These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23113253)

  • 1. Modification of normal activities of angiotensin II and angiotensin IV in rats with experimental hypo- and hyperglycemia.
    Pevtsova EI; Tolpygo SM; Loseva TN; Kotov AV
    Bull Exp Biol Med; 2012 Sep; 153(5):667-70. PubMed ID: 23113253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral and Hemodynamic Effects of Free and Protein-Bound Angiotensin IV in Rats in Experimental Hypo- and Hyperglycemia: Comparative Aspects.
    Tolpygo SM; Pevtsova EI; Kotov AV
    Bull Exp Biol Med; 2015 Jul; 159(3):297-301. PubMed ID: 26205719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of the effects of free bound and carrier protein angiotensin II in experimental hypoglycemia and hyperglycemia.
    Tolpygo SM; Pevtsova EI; Shoibonov BB; Kotov AV
    Bull Exp Biol Med; 2014 Feb; 156(4):419-22. PubMed ID: 24771417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Physiological role of angiotensin II and IV as active components of the renin-angiotensin system].
    Prozherina IuA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2008; 58(6):649-62. PubMed ID: 19178068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexes of angiotensin IV with functionally different proteins in the regulation of drinking behavior and hemodynamics in rats.
    Pevtsova EI; Tolpygo SM; Obukhova MF; Kotov AV
    Bull Exp Biol Med; 2009 Nov; 148(5):738-41. PubMed ID: 20396781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic hemodynamic function in humans with type 1 diabetes treated with protein kinase Cβ inhibition and renin-angiotensin system blockade: a pilot study.
    Cherney DZ; Reich HN; Scholey JW; Lai V; Slorach C; Zinman B; Bradley TJ
    Can J Physiol Pharmacol; 2012 Jan; 90(1):113-21. PubMed ID: 22188532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in the renal vascular response to angiotensin II involves the Mas receptor.
    Safari T; Nematbakhsh M; Hilliard LM; Evans RG; Denton KM
    Acta Physiol (Oxf); 2012 Oct; 206(2):150-6. PubMed ID: 22775972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free and protein-bound angiotensin II(1-7)in the regulation of drinking behavior and hemodynamics in rats.
    Tolpygo SM; Pevtsova EI; Shoibonov BB; Kotov AV
    Bull Exp Biol Med; 2012 Sep; 153(5):623-6. PubMed ID: 23113241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of atrial natriuretic factor on the vasoconstrictor actions of the renin-angiotensin system in conscious rats.
    Lappe RW; Todt JA; Wendt RL
    Circ Res; 1987 Jul; 61(1):134-40. PubMed ID: 3038365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of hemodynamic parameters under conditions of systemic administration of angiotensin II and angiotensin IV to rats after carotid glomectomy.
    Pevtsova EI; Serova ON; Shevchenko LV; Elfimov AI; Kotov AV; Torshin VI
    Bull Exp Biol Med; 2011 Nov; 152(1):9-11. PubMed ID: 22803026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
    Vora JP; Oyama TT; Thompson MM; Anderson S
    Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of the renin-angiotensin and kallikrein-kinin systems to short-term variability of blood pressure in two-kidney, one-clip hypertensive rats.
    Ponchon P; Elghozi JL
    Eur J Pharmacol; 1996 Feb; 297(1-2):61-70. PubMed ID: 8851167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.
    Babiker F; Al-Jarallah A; Joseph S
    PLoS One; 2016; 11(11):e0165777. PubMed ID: 27814397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of angiotensin II in the kidney.
    Toke A; Meyer TW
    Contrib Nephrol; 2001; (135):34-46. PubMed ID: 11705290
    [No Abstract]   [Full Text] [Related]  

  • 15. Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies.
    Patel S; Rauf A; Khan H; Abu-Izneid T
    Biomed Pharmacother; 2017 Oct; 94():317-325. PubMed ID: 28772209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive activation of the renin-angiotensin system reduces visceral fat and improves glucose tolerance in mice.
    Favre GA; Lebrun P; Lopez P; Butori C; Hofman P; Esnault VL; Van Obberghen E
    J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):396-409. PubMed ID: 25371094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats.
    Paula RD; Lima CV; Khosla MC; Santos RA
    Hypertension; 1995 Dec; 26(6 Pt 2):1154-9. PubMed ID: 7498987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin IV in the central nervous system.
    von Bohlen und Halbach O
    Cell Tissue Res; 2003 Jan; 311(1):1-9. PubMed ID: 12483279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of angiotensin II in diabetic nephropathy.
    Kennefick TM; Anderson S
    Semin Nephrol; 1997 Sep; 17(5):441-7. PubMed ID: 9316212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of angiotensin II antagonist eprosartan on hyperglycemia-induced activation of intrarenal renin-angiotensin system in healthy humans.
    Osei SY; Price DA; Laffel LM; Lansang MC; Hollenberg NK
    Hypertension; 2000 Jul; 36(1):122-6. PubMed ID: 10904023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.